The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The Egyptian Ministry of Antiquities is pleased to announce the launch of an egyptian – international Project using non-invasive and non-destructive surveying techniques for the scanning of Egyptian Pyramids under the title “ScanPyramids” project.
Just because a mystery is 4500 years old doesn’t mean it can’t be solved…” This could be the motto of the exceptional scientific mission launched October 25, 2015, under the authority of the Egyptian Ministry of Antiquities, initiated, designed and coordinated by the Faculty of Engineering of Cairo and the French HIP.Institute (Heritage, Innovation and Preservation). Radiographic muons, aka cosmic particles, infrared thermography, photogrammetry, scanner and 3D reconstruction: the most innovative technologies will be used by researchers of international renown and three major universities: the Faculty of Engineering of Cairo University, Université Laval of Quebec and Nagoya University of Japan. Their goal: to probe the heart of the largest pyramids of Egypt, without drilling the slightest opening.
Four millennia after their construction, these ancient giants are far from having yielded their secrets. The first mystery concerns their construction, especially Khufu, the last of the Seven Wonders of the Ancient World still existing: it is still impossible to describe with certainty how this stone monument, the largest ever built by humans, was erected.
The “ScanPyramids” project has already been approved by the permanent committee of the Ministry of Antiquities and has obtained all necessary permissions from concerned authorities. With a base of more than 5 hectares, its original height of almost 150 meters and a mass of 5 million tons, how was it possible to construct such a wonder in only 25 years?
To view the multimedia release go to:
http://www.multivu.com/players/uk/7671551-scanpyramids-project-launch-egyptian/
As more than 2 million freshman head off to college, they enter one of the most dangerous times for harmful and underage student drinking—the first six weeks of their first year. And while there are numerous options available to address student drinking -- they are not all equally effective.
WHAT: The NIH’s National Institute on Alcohol Abuse and Alcoholism will hold a press briefing to announce the CollegeAIM (Alcohol Intervention Matrix) guide and website – the centerpiece of which is a new comprehensive and easy-to-use tool that will help inform decisions about alcohol interventions and guide college staff to science-based strategies.
Developed with input from leading alcohol researchers and college staff, CollegeAIM is distinctive because of the number and expertise of its contributors, the breadth of research covered by its analysis, and its user-friendly format.
To view the multimedia release go to:
http://www.multivu.com/players/English/7587851-niaaa-collegeaim-alcohol-intervention/
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to funding children’s cancer research, is recognizing National Childhood Cancer Awareness Month with a number of activities planned throughout September. As the leading non-governmental funder of childhood cancer research grants, St. Baldrick’s is asking people to get involved by helping to raise awareness and funds for childhood cancer research.
“One in five kids with cancer will die in the first five years of diagnosis, and those that do survive face a lifetime of serious health issues caused by the toxicity of their cure,” said Kathleen Ruddy, CEO of St. Baldrick’s. “The American public wants kids with cancer to be a national health priority, but our leaders are leaving these kids behind with the lack of federal research funding. We are calling upon everyone to speak up about the need for increased childhood cancer research funding as well as to stand up in support of kids with cancer during this important month.”
Today, as part of the official kickoff for Childhood Cancer Awareness Month, St. Baldrick’s will ring the opening bell at the NASDAQ Stock Market. St. Baldrick’s board members will be joined by researchers, as well as children and families directly affected by childhood cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7610751-st-baldricks-childhood-cancer-awareness-month/
Politicians, economists, media and researchers from around the world will gather in Tunis from May 14 to 17 to take part in the Global Forum on Modern Direct Democracy. As the forum's media partner, SWI swissinfo.ch will report live from the event, and officially launch its microsite dedicated to direct democracy and its partner site, people2power.info.
The aim of the microsite swissinfo.ch/directdemocracy - online in 10 languages since December 2014 - is to inform readers about political rights and democratic processes so they can form their own opinions in order to play a greater role in the decision-making process. Switzerland's unique form of participative democracy is the focus of the site whereas people2power.info offers a global view.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523351-swissinfo-direct-democracy-tunis/
Politicians, economists, media and researchers from around the world will gather in Tunis from May 14 to 17 to take part in the Global Forum on Modern Direct Democracy. As the forum's media partner, SWI swissinfo.ch will report live from the event, and officially launch its microsite dedicated to direct democracy and its partner site, people2power.info.
The aim of the microsite swissinfo.ch/directdemocracy - online in 10 languages since December 2014 - is to inform readers about political rights and democratic processes so they can form their own opinions in order to play a greater role in the decision-making process. Switzerland's unique form of participative democracy is the focus of the site whereas people2power.info offers a global view.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523351-swissinfo-direct-democracy-tunis/
Living Off the Grid - http://www.thriveoffthegrid.com/ - See how others are living offgrid using the advantages of wind and solar energy plus more for off grid power and ...
Living off the grid you must take advantage of renewable energy. This renewable resource originates from several sources, consisting of sun, wind and water, to start with ...
Researchers are constantly on the lookout for more ways of making green energy. Here are the 2 types you must understand now.
Living off the Grid: - Advantages of Solar Power
i. The energy that originates from simply one hour of sun suffices to supply energy for a year for the whole world
ii. A battery can be used to store off grid solar power for evenings and cloudy days
iii. Solar panels on a roof work when the sun's rays strike the cells in the panel and electrons are released, producing energy
iv. Using solar power will typically provide a saving of $100+ each month on utility costs for the property owners of off grid homes .
Living off the Grid: - Advantages of Wind Energy
i. When wind goes through the blades of a turbine that is connected to a generator, the energy produced by the spin is converted into electrical energy
ii. A single large wind turbine can provide electricity for around 500 off grid homes
iii. Last year, 42 % of the houses that were geared up with a source of off grid power used wind
iv. Unlike most other sources of energy, wind utilizes hardly any water; not only is wind energy carbon neutral, it helps water conservation also
v. There is around 10 times the amount of wind available in the U.S. than is needed to supply power for the whole country
vi. Wind energy is presently the fastest-growing source of renewable energy: - Around two wind farms are set up weekly in the U.S.
For living off the grid, the facts indicate that the advantages of solar power combined with the advantages of wind energy now exceed any advantages that fossil fuels may have had. However it is probably down to individuals to begin the shift to a larger scale adoption, so that we may all enjoy living off the grid.
A recently published scientific study from Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that subjects who were trying to lose weight and used the patented spinach extract Appethyl on a daily basis lost 43 percent more weight compared to those ingesting a placebo.
In this clinical trial, overweight women were given either a daily five gram dose of Appethyl or a control drink immediately before breakfast. Researchers found that the weight of the women ingesting Appethyl decreased significantly at 43 percent more than subjects ingesting the control drink.
This is one of three studies that also compared the effects of Appethyl after 90 days with those found after the first dose and found no decline of effects, indicating that Appethyl takes effect after the first dose and is just as effective after long-term use. One study showed that Appethyl reduced hunger by 25 percent four hours after consumption, in addition to reducing thoughts about food by 33 percent.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7426951-appethyl-spinach-extract/
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
